VSF Projects Ltd is offering a Right Issue valued at Rs 49.33 Crores. The subscription for this Right Issue will be open from June 5, 2024 to June 20, 2024. For every fully paid-up equity share held on the record date of May 24, 2024, shareholders are entitled 3 Rights equity shares for every 2 fully paid-up equity shares held on record date. The face value of each share is Rs. 10, with the Right Issue price set at Rs. 50.
Corporate Action | |
---|---|
Security Name | VSF Projects Ltd |
Issue Open/Close | June 5, 2024-June 20, 2024 |
Record Date | May 24, 2024 |
Issue Size (Amount) | ₹49.33 Crores |
Issue Size (Shares) | ₹9,865,121 |
Right I ssue Price | ₹50 per share |
Face Value | ₹10 Per Shares |
CMP | ₹53 |
Renunciation of Rights Entitlements | June 13, 2024 |
Terms of Payment | Rs. 25 on application. Rs 25 in one or more subsequent calls as determined by the board |
Entitlement | 3 Rights equity shares for every 2 fully paid-up equity shares held on record date |
Disclaimer: The Information compiled by CEBPL on a best efforts basis from information CEBPL received from third party vendors, believed to be reliable. The information may contain errors or omissions; and is subject to change without prior or additional notice. CEBPL provides corporate action information that may be of interest or relevance to CEBPL clients. This does not constitute a recommendation or advice by CEBPL, and CEBPL Clients may not rely upon it. CEBPL does not warrant that the information provided is accurate, timely, or complete. CEBPL Clients are urged to verify the information prior to using it in their investing and trading decisions, including, but not limited to, referral to independent financial news resources, company announcements, and regulatory filings or disclosures. "Investment in securities market are subject to market risks, read all the related documents carefully before investing". Registration granted by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of retums to investors. Name of Compliance Officer-Prashant Salian Email Id-Prashant.salian@choiceindia.com Contact no. 022-67079999-Ext-2310. Name of Grievance Officer-Deepika Singhvi-Email Id-ig@choiceindia.com, Contact no. 022-67079999-Ext-834. www.choiceindia.com
Invest in best pharma mutual funds in India for 2020 with Investica. Explore our top recommended pharma mutual funds to start investing today.